{
  "pmcid": "12182882",
  "sha256": "3dc83830b26869d581a907c96854549455482331399f88304d6674a4c12c568f",
  "timestamp_utc": "2025-11-09T22:17:55.565568+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.699383640552998,
    "reading_ease": 27.288123079877124,
    "word_count": 217
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Multimodal Therapies for Early-Stage Malignant Pleural Mesothelioma"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was performed using a computer-generated sequence"
      },
      "Participants": {
        "score": 1,
        "evidence": "Participants were selected based on eligibility criteria, focusing on early-stage MPM"
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention included multimodal therapies such as extrapleural pneumonectomy and extended pleurectomy/decortication, compared to standard care"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy and safety of multimodal therapies for early-stage MPM"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was quality of life, measured over a 12-month period"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, with allocation concealment via sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 564 participants were randomised, with 282 in the intervention group and 282 in the control group"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was conducted using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The meta-analysis found no statistically significant differences between groups in physical function (SMD: -0.34, 95% CI: -1.14 to 0.45), social function (SMD: 0.01, 95% CI: -0.52 to 0.53), or lethargy (SMD: -0.34, 95% CI: -0.96 to 0.27)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar across groups, with moderate heterogeneity (IÂ²: 47%-76%)"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}